Anion exchange (AE) proteins are present in hum an neurons in the brain. Im m unohistochem ical data indicate that their apparent expression level increases with age, and especially with degeneration in Alzheimer's disease-affected brain areas. The increase in im m unoreactivity is probably caused by changes in AE structure that lead to an increased accessibility o f hitherto hidden epitopes. These epitopes correspond to regions in the m em brane dom ain that are involved in genera tion of senescent cell-specific antigen from AE I in aging eryth rocytes. Elucidation o f the m olecular nature of these changes and the underlying mechanisms, will lead to insight in the pro cesses that govern aging-and degeneration-associated pertur bation of m em brane integrity. AE-mediated chloride/bicar bonate exchange is a m ajor com ponent in the regulation of intracellular pH. The functional consequences o f changes in AE structure m ay range from acidosis, disturbance of cytoskeleton integrity, and untim ely or im paired recognition o f cells by components of the im m une system, such as microglia. A molecular and physiological description of these changes will establish AE proteins as valuable tools in elucidating the pro cesses of normal aging, and the disturbances in aging-related diseases such as Alzheimer's disease.
Introduction
Proteins of the anion exchanger (AE) gene family have been found in all cells examined so far [1] [2] [3] . The AE proteins share a C-terminal, highly homologous membrane domain (~ 50 kD) that is mainly responsible for anion exchange, and a more variable N-terminal, cytoplasmic domain (50-80 kD) that binds cytoskeletal and other peripheral proteins. The functions of erythrocyte AE1 (or band 3), the most extensively studied member of this family, are the exchange of chloride and bicar bonate across the plasma membrane, thereby facilitating transport of carbon dioxide through the body, and anchoring the spectrin/ actin cytoskeleton to the plasma membrane, by providing a binding site for ankyrin [2] , In addition, the cytoplasmic domain may play a role in regulation of anion transport activity [4] , as well as in the regulation of cell metabo lism by the binding of glycolytic enzymes such as glyceraldehyde-3-phosphate dehydroge nase [5, 6] . In other cells, the anion transport activity of AE1 and other AE proteins is involved in regulation of intracellular pH, chloride concentration, and cellular volume [7] [8] [9] . AE1 and AE3, but not AE2 or the trun cated variants of AE1, have a high affinity for ankyrin [10] . The more extensive variation in the cytoplasmic domain may reflect the varia tion in cell type-specific cytoskeleton architec ture.
AE1 has also been identified as the precur sor of the senescent cell-specific antigen (SCA), responsible for recognition and subse quent removal of old and damaged erythro cytes by the immune system [11] , Changes in AE1 conformation, presumably triggered by oxidation and/or proteolytic degradation, oc cur during normal erythrocyte aging. These changes do not only affect anion transport and the interaction of AE1 with the cytoskele ton, but also result in the appearance of the neoantigen SCA. Binding of SCA by autolo gous IgG, possibly in a complex with C3b [12] , leads to recognition and removal of old cells from the circulation by macrophages. The process that generates SCA from AE1, which may be accelerated during organismal aging [ 13] , is active in other cell types as well [111- Aging is the most important risk factor for Alzheimer's disease (AD): the neuropsycho logical and the neuropathological characteris tics o f AD show a broad overlap with the characteristics of normal, physiological aging [14] [15] [16] [17] [18] . Normal brain aging is accompanied by a num ber of changes, such as apparent neuron loss in hippocampus and cortex areas, accumulation of lipofuscin, an increase in the num ber o f corpora amylacea, a gradual accu m ulation of amyloid plaques and neurofibril lary tangles, and an increase in number and/ or reactivity of astrocytes [14-16, 18], The neuronal membrane is probably the site at which aging-related changes most directly af fect cellular homeostasis [19] . Aberrant pro cessing and cleavage of amyloid precursor protein ((3APP), as well as abnormal phos phorylation of tau, are likely to be involved in the etiology of the AD-specific lesions amyloid plaques and neurofibrillary tangles [20, 21] . We propose that these events are secondary to and signposts of perturbation of neuronal membranes. This hypothesis is based on observations as: (1) the cleavage sites o f the A|3 peptide, as well as the identi fied mutations in (3APP, are all located with in or close to the putative membrane domain of (3APP [20]; (2) minute lesions in the neu ronal membrane probably precede deposition of A(3 in diffuse plaques [22] ; (3) structural and functional analyses have revealed ADrelated alterations in neuronal membranes [19, [23] [24] [25] ; (4) recently, mutations in two related genes that encode integral membrane proteins were identified as responsible for over 80% of the cases of familial Alzheimer's disease [26, 27] . These mutations are located close to predicted membrane-spanning re gions of these proteins. Together, these data suggest that aging-related phenom ena are more pronounced in the AD-affected brain, and are concentrated at the neuronal mem brane, but they provide no clues to the un derlying mechanisms. It has been put for ward that AD-related changes in cellular membranes could result in changes in signal transduction, similar to those observed dur ing normal aging in neural and nonneural cells [28] .
Considering the central position of changes in structure and function of AE1 in erythro cyte aging, the emerging central role of AE proteins in cellular homeostasis, and especial ly the apparent changes in AE protein struc ture that occur during aging and degeneration in the human neuron, we see the AE proteins as the common denominators of physiological and pathological neuronal aging in the hum an brain. Here we will review the data th at have led to this view, and present and discuss new data that support and extend it.
Materials and Methods

Neuropathology and Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue from control and AD patients (up to 10 h postmortem) was used for neuropathological examination and diagnosis as described before [29] [30] [31] [32] [33] [34] . Plaques and tangles were encountered only sporadically in the brains of control patients. Immunohistochemistry was performed on formaldehyde or paraformaldehyde/sublimat-fixed tis sue. Sections were counterstained with hematoxylin. Control incubations contained preimmune sera. Immunostaining was performed with the avid in-biotinperoxidase technique [29] [30] [31] [32] [33] [34] .
Immunoblotting
Immunoblot analysis was performed on frozen tis sue fractions from the same brains used for neuropa thological and immunohistochemical analysis, using antiserum dilutions of 1:200-1:500, as described be fore [29] [30] [31] [32] [33] [34] .
Antibodies
The polyclonal antibody WP944 was raised against a soluble part of the cytoplasmic domain of erythrocyte AE1 [Bosman et 
pH Measurements
The contribution of the various ion transporters to the regulation of intracellular pH was determined with the fluorescent probe 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (Molecular Probes, Eugene, Oreg., USA), following the procedures described be fore [36, 37] .
Cell Lines
The neuroblastoma cell line IMR-32 (American Type Culture Collection, Rockville, Md., USA) was cultured in RPMI medium (Dutch modification) con taining 10% fetal calf serum (Life Technologies, Breda, The Netherlands).
Results and Discussion
Early in the recent explosion o f research on Alzheim er's disease, it was postulated that accelerated cellular aging in general, and neu ronal aging in particular, might lie at the ori gin of AD [14] . This hypothesis was difficult to falsify, as little was known about the nor m al neuronal aging process. In contrast, the aging-related changes in structure and func tion o f erythrocyte AE1 constitute a useful paradigm for the final stages in the cellular aging process [11] . M easurem ent of agingrelated param eters of erythrocyte AE1 sug gested that the cellular aging process is dis turbed in patients with Alzheim er's disease [38] . Com parison with other types of dem en In Alzheimer's disease-affected brain ar eas, some anti-AEl antisera show an in creased immunoreactivity especially in large pyramidal cells with a degenerative morphol ogy that do not (yet) contain mature neurofi brillary tangles [30, 45] . An increased immunoreactivity, both in the number of reactive cells and in the reactivity per cell, is observed especially with antibodies against epitopes of the membrane domain of AE1 ( fig. ID, E) . Antibodies against the cytoplasmic domain of AE1 or AE2 do not show this increase ( fig. 1A-C ;V\ : 1
• .*> . -. have been reported with an antiserum against a peptide consisting of amino acids 812-827 of AE1 [45] . This antiserum also stained amy loid plaques, as did the antibody against a peptide in the fourth extracellular loop of AE1 ( fig. ID) . In general, those antibodies against membrane-bound epitopes that react espe cially with polypeptides smaller than intact AE proteins on brain immunoblots, or with erythrocyte AE1 fragments generated in vitro, show increased immunoreactivity in sections of AD-affected brain areas when compared with control sections [34, 47] . The changes in immunoreactivity are accompanied by changes in anion transport [48] .
From such data we conclude that neuronal AE proteins undergo specific structural changes in the membrane of aging and espe cially degenerating neurons. Such changes re sult in a conformation that is recognized by antisera directed against epitopes of the m em brane domain, which are not accessible in the healthy neuron. The strongest reactions are observed with antisera against components of the senescent cell antigen SCA that originates from AE1 in aging erythrocytes [11] . This conclusion indicates that the processes that lead to SCA generation from AE1 in aging erythrocytes may also occur in aging and de generating neurons in the human brain. At present, there is only circumstantial evidence for the molecular nature of these processes, such as aging-associated oxidation, either in AE1 itself or in other membrane components, and/or activation of specific proteases [11] .
A num ber of considerations, however, cloud the view sketched above. First, the known members of the AE family share a high degree of homology in their membrane do main [3] , including the epitopes that display increased expression in aging and AD-af fected neurons. As at least three AE proteins are present in human neurons [33], it is not clear which AE proteins in which type of neu rons are responsible for the phenomena ob served so far. Second, not all AE isoforms and variants may be equally detectable. We have observed in AD brains an immunoreaction in neurons, e.g. granule cells in the dentate gyrus, that were negative in nondemented brains [47] . In addition, we have seen AE immuno reaction only in neuronal cells, whereas others have found indications for the presence of AE proteins in astroglia as well [11, 49] . These results may be caused by the ability of antisera against membrane epitopes to reach these epi-topes only in degraded and/or incomplete AE1 molecules [34] . Third, the increasing number of splice variants within the AE fami ly constitutes another complicating factor. For example, not only are there a num ber of AE1 variants with different cytoplasmic do-> + mains [3, 50] , some AE proteins may have a complete cytoplasmic domain, but a consider ably shortened membrane domain [51] . The, mostly undocumented, reports of unexpected mRNAs that may lack variable parts of the membrane domain [1, 13] add to the suspi cion that there may be a plethora or AE iso forms 'out there'. A careful com bination of immunocytochemical and in situ hybridiza tion methods will be necessary to distinguish between the numerous possibilities. Finally, various isoforms may end up in various cell compartments, depending on interaction of the cytoplasmic domain with cytoskeletal pro teins such as ankyrin early in the synthesis pathway [50, 52] , and/or the presence of spe cific sorting signals. It is noteworthy that an antiserum raised against a cytoplasmic frag ment of AE1 is the only antiserum so far, that shows a reactivity concentrated at the plasma membrane ( fig. 1C) . Most other antisera dis play a mostly intracellular, dotted pattern [30, 53] . The anti-ankyrin antiserum stains both neurons and astrocytes ( fig. IF) . This is, to our knowledge, the first immunohistochemical evidence for the presence of ankyrin-like proteins in the human brain. We could not demonstrate an Alzheimer-related degrada tion of ankyrin, as shown for fodrin, another neuronal cytoskeleton protein [45] . This is probably due to the sensitivity of ankyrin to degradation [Pinder, pers. commun.] that may occur even during very short (3 h) post mortem delay and subsequent tissue fragmen tation [Bosnian et a l, unpubl. results]. This conclusion is supported by the considerable interindividual variation that is shown by As discussed above, structural changes in the AE m em brane dom ain are the m ost con spicuous phenom ena in AE proteins in the degenerating hum an neuron. The m em brane dom ains o f the known AE proteins are all involved in chloride/bicarbonate exchangerelated regulation of intracellular pH [1,2], In order to assess the relative im portance of intact AE activity in m aintenance of pHi, we m easured the capacity of IM R-32 neuroblas tom a cells -a cell line that is also used as a model system to investigate AD-related pro cesses [55] -to regulate pH i in various cir cumstances. In these cells, pH i recovery after acidosis is incom plete in th e absence of bicar bonate ( fig. 3A) , but cells do recover in the presence of bicarbonate ( fig. 3B ). This recov ery is completely inhibited by DIDS, a highaffinity ligand of AE proteins ( fig. 3C) , and only partially dependent on extracellular sodi um ( fig. 3C ). These data indicate that bicar bonate transport across the neuronal m em brane is the m ajor pHi-regulatory system in neuronal cells, and that at least part o f the bicarbonate transport can be contributed to AE-catalyzed chloride/bicarbonate exchange. er from an acid load using the NH4CI prepulse method [36, 37] in the absence of external bicarbon ate. B Cells do recover when bicar bonate is present. Recovery is com pletely inhibited by DIDS, an in hibitor of chloride/bicarbonate ex change, and a high-affinity ligand of AE proteins. This inhibition is, at least partly, reversible. C Recov ery from an acid load is partially independent of the presence of ex tracellular sodium, indicating the activity of a sodium-independent chloride/bicarbonate exchange sys tem. Tima (a) cellular homeostasis in general [56] . In neu rons, regulation of pHi is involved in regula tion of voltage-activated calcium signals, and neurotransmitter release and uptake [57] . These results w arrant the conclusion that a major consequence of aging-and degeneration-associated changes in AE proteins in neu ronal cells will be a disturbance of the regula tion of intracellular pH, with deleterious ef fects on neuronal homeostasis and function.
Conclusions
Neuronal aging and degeneration are ac companied by changes in AE structure. These changes are most conspicuous in the mem brane domain, and resemble the alterations that occur in aging erythrocytes. In the latter, changes in AE1 structure lead to a decrease in anion transport capacity, to decreased bind ing of the cytoskeleton protein ankyrin, and to generation of a neoaritigen. This senescent cell-specific antigen is recognized by the im mune system, which results in phagocytosis of old and damaged cells. Against this back ground, establishment of the identity of the AE protein(s) involved in neuronal aging and degeneration, together with a molecular de scription of the accompanying changes in AE structure, will illum inate the processes that are involved in aging-related loss of mem brane integrity. In our view of the central position of AE proteins in cellular homeosta sis in general, the observed structural changes in human neurons may have severe functional consequences, similar to those observed in aging erythrocytes. A m ore extensive discus sion of the putative mechanism(s) of cell death in Alzheimer's disease, i.e. apoptosis and/or necrosis, is beyond the scope of this article [58] . However, the major processes in both necrosis and apoptosis may well be asso ciated with a compromised AE integrity. For example, AE-mediated anion transport is a m ajor factor in regulation of intraneuronal pH , and disturbance o f pH regulation has been suggested to be causally associated with various stages in the apoptosis process, e.g. through activation of a specific endonuclease [59, 60] , Also, perturbation of the membranecytoskeleton interaction has been postulated to play a m ajor role in the initial stages o f neu ronal degeneration in A D [61] . The first events in this perturbation may very well be sought in the interaction of the cytoplasmic dom ain of an AE protein and one or more cytoskeletal proteins. The m ore so, as this interaction is regulated by intracellular cal cium concentration and state of phosphoryla tion [62, 63] , both o f which are considered to be im portant players on the Alzheimer stage [64, 65] , A nother im portant role, in physio logical apoptosis and in the Alzheimer pathol ogy, is played by microglia, the macrophages of the brain [66] . Normally, plasma m em brane integrity is m aintained until late in the course of the apoptotic process, until m em brane-bound cellular remains are removed by macrophages, thereby m inimizing inflam m a tion. W hen the apoptosis load is high, as may be the case in AD [58] , the microglia clearance system may fail, resulting in necrosis, induc tion o f inflam m atory responses, and further tissue damage. The putative role of AE-related antigens in the im paired or untim ely recog nition of dying and dead cells (or fragments) by microglia is an as yet unexplored, but fasci nating avenue.
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